Original article by Carrie LaFrenz
The Australian Financial Review – Page: 1 & 16 : 12-Dec-23
Sigma Health has forecast that its merger with Chemist Warehouse will generate annual cost savings of $60m. The combined group will boost EBIT in excess of $495m and a market capitalisation of about $8.8bn. Chemist Warehouse operates a network of more than 600 franchised stores, while Sigma owns the Amcal and Discount Drug Store brands and a pharmaceuticals wholesaling arm. The merged group will be headed by Sigma CEO Vikesh Ramsunder and chairman Michael Sammells. Chemist Warehouse CEO and co-founder Mario Verrocchi says that listing the company on the sharemarket is a "life dream". Further expanding the Chemist Warehouse brand overseas will be part of the merged group’s 100-year growth strategy.
CORPORATES
SIGMA HEALTHCARE LIMITED – ASX SIG, CHEMIST WAREHOUSE